Global Artificial Vital Organs Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Artificial Vital Organs Market Research Report 2024
Artificial organ is man-made machine or device that is used to replace the functions of missing or faulty organ and restores the functions of original organ.
According to MRAResearch’s new survey, global Artificial Vital Organs market is projected to reach US$ 47130 million in 2033, increasing from US$ 26020 million in 2022, with the CAGR of 8.7% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Artificial Vital Organs market research.
Increasing organ failure and disability due to age-related disorders, new and modified technologies, increasing accidents and injuries leading to organ deletion, rise in number of people awaiting organ transplants and lack of donors are the major drivers responsible for the growth of this market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Artificial Vital Organs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Edwards Lifesciences Corporation
Abbott Diabetes Care
Baxter International
Ekso Bionics
Asahi Kasei Medical
Jarvik Heart
Ottobock Healthcare
Abiomed Inc
Boston Scientific Corporation
Ossur
Medtronic
Zimmer Biomet
Heartware International, Inc
SynCardia Systems, LLC.
Iwalk, Inc.
Berlin Heart Gmbh
Biomet, Inc
CARMAT
Cleveland Heart
MyLVAD
Cirtec Medical Systems
Thoratec Corporation
Fresenius Medical Care AG & Co. KGaA
Cyberonics, Inc
F. Hoffmann-La Roche Ltd
BiVACOR
Segment by Type
Artificial Liver
Artificial Heart
Artificial Pancreas
Artificial Kidney
Artificial Lungs
Others
Hospitals
Clinics
Research Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Artificial Vital Organs report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Artificial Vital Organs market is projected to reach US$ 47130 million in 2033, increasing from US$ 26020 million in 2022, with the CAGR of 8.7% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Artificial Vital Organs market research.
Increasing organ failure and disability due to age-related disorders, new and modified technologies, increasing accidents and injuries leading to organ deletion, rise in number of people awaiting organ transplants and lack of donors are the major drivers responsible for the growth of this market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Artificial Vital Organs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Edwards Lifesciences Corporation
Abbott Diabetes Care
Baxter International
Ekso Bionics
Asahi Kasei Medical
Jarvik Heart
Ottobock Healthcare
Abiomed Inc
Boston Scientific Corporation
Ossur
Medtronic
Zimmer Biomet
Heartware International, Inc
SynCardia Systems, LLC.
Iwalk, Inc.
Berlin Heart Gmbh
Biomet, Inc
CARMAT
Cleveland Heart
MyLVAD
Cirtec Medical Systems
Thoratec Corporation
Fresenius Medical Care AG & Co. KGaA
Cyberonics, Inc
F. Hoffmann-La Roche Ltd
BiVACOR
Segment by Type
Artificial Liver
Artificial Heart
Artificial Pancreas
Artificial Kidney
Artificial Lungs
Others
Segment by Application
Hospitals
Clinics
Research Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Artificial Vital Organs report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source